Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates

by Georgia D. Tomaras, Barton F. Haynes
Published 2013-12-01

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.

by Laurent Verkoczy, Garnett Kelsoe, Barton F Haynes
Published 2014-05-01

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies

by Garnett Kelsoe, Laurent Verkoczy, Barton F. Haynes
Published 2013-12-01

HIV mRNA Vaccines—Progress and Future Paths

by Zekun Mu, Barton F. Haynes, Derek W. Cain
Published 2021-02-01

Coping with viral diversity in HIV vaccine design: a response to Nickle et al.

by Will Fischer, H X Liao, Barton F Haynes, Norman L Letvin, Bette Korber
Published 2008-01-01

Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART® Molecules

by Marina Tuyishime, Amir Dashti, Katelyn Faircloth, Shalini Jha, Jeffrey L. Nordstrom, Barton F. Haynes, Barton F. Haynes, Barton F. Haynes, Guido Silvestri, Ann Chahroudi, Ann Chahroudi, Ann Chahroudi, David M. Margolis, David M. Margolis, David M. Margolis, David M. Margolis, Guido Ferrari, Guido Ferrari
Published 2021-08-01

Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency

by Todd Bradley, Guido Ferrari, Barton F. Haynes, David M. Margolis, Edward P. Browne
Published 2018-10-01

BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell Tolerance

by Masayuki Kuraoka, Pilar B. Snowden, Takuya Nojima, Laurent Verkoczy, Barton F. Haynes, Daisuke Kitamura, Garnett Kelsoe
Published 2017-02-01

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins

by Barton F. Haynes, Dimiter S. Dimitrov, Huaxin Liao, Gerald V. Quinnan, Christopher C. Broder, Zhongyu Zhu, Weizao Chen
Published 2010-02-01

Improving defences at the portal of HIV entry: mucosal and innate immunity.

by Robin J Shattock, Barton F Haynes, Bali Pulendran, Jorge Flores, José Esparza, Working Group convened by the Global HIV Vaccine Enterprise
Published 2008-04-01

Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection

by Naveen K. Vaidya, Ruy M. Ribeiro, Ruy M. Ribeiro, Pinghuang Liu, Barton F. Haynes, Georgia D. Tomaras, Alan S. Perelson
Published 2018-06-01

Subordinate Effect of -21M HLA-B Dimorphism on NK Cell Repertoire Diversity and Function in HIV-1 Infected Individuals of African Origin

by Elia Moreno Cubero, Ane Ogbe, Isabela Pedroza-Pacheco, Myron S. Cohen, Barton F. Haynes, Persephone Borrow, Dimitra Peppa, Dimitra Peppa
Published 2020-02-01

High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers.

by Olivier Lambotte, Justin Pollara, Faroudy Boufassa, Christiane Moog, Alain Venet, Barton F Haynes, Jean-François Delfraissy, Asier Saez-Cirion, Guido Ferrari
Published 2013-01-01

Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region.

by Laurent Verkoczy, M Anthony Moody, T Matt Holl, Hilary Bouton-Verville, Richard M Scearce, Jennifer Hutchinson, S Munir Alam, Garnett Kelsoe, Barton F Haynes
Published 2009-10-01

Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes.

by Geoffrey O Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E Grandpre, Michael W Panas, Michael S Seaman, Barton F Haynes, Norman L Letvin
Published 2011-08-01

Correction: Thy1 Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes.

by Geoffrey O. Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E. Grandpre, Michael W. Panas, Michael S. Seaman, Barton F. Haynes, Norman L. Letvin
Published 2011-08-01

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.

by Nathanael P McCurley, Arban Domi, Rahul Basu, Kevin O Saunders, Celia C LaBranche, David C Montefiori, Barton F Haynes, Harriet L Robinson
Published 2017-01-01

Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site

by Aaron G. Schmidt, Khoi T. Do, Kevin R. McCarthy, Thomas B. Kepler, Hua-Xin Liao, M. Anthony Moody, Barton F. Haynes, Stephen C. Harrison
Published 2015-12-01

Contributions of Mamu-A*01 status and TRIM5 allele expression, but not CCL3L copy number variation, to the control of SIVmac251 replication in Indian-origin rhesus monkeys.

by So-Yon Lim, Tiffany Chan, Rebecca S Gelman, James B Whitney, Kara L O'Brien, Dan H Barouch, David B Goldstein, Barton F Haynes, Norman L Letvin
Published 2010-06-01

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction

by Sophie M.-C. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Kartik Manne, Victoria Stalls, Megan F. Kopp, Rory Henderson, Robert J. Edwards, Barton F. Haynes, Priyamvada Acharya
Published 2021-01-01